Chung CL, Lee TJ, Akiba M, Lee HH, Kuo TH, Liu D, Ke HM, Yokoi T, Roa MB, Lu MJ, Chang YY, Ann PJ, Tsai JN, Chen CY, Tzean SS, Ota Y, Hattori T, Sahashi N, Liou RF, Kikuchi T, Tsai IJ (2017)
Comparative and population genomic landscape of Phellinus noxius: A hypervariable fungus causing root rot in trees
Mol Ecol 26: 6301

Oda S, Fukami T, Yokoi T, Nakajima M (2015)
A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development
Drug Metab Pharmacokinet 30: 30

Ito Y, Fukami T, Yokoi T, Nakajima M (2014)
An Orphan Esterase ABHD10 Modulates Probenecid Acyl Glucuronidation in Human Liver
Drug Metabolism & Disposition: The Biological Fate of Chemicals 42: 2109

Muta K, Fukami T, Nakajima M, Yokoi T (2014)
N-Glycosylation during translation is essential for human arylacetamide deacetylase enzyme activity
Biochemical Pharmacology 87: 352

Shimizu M, Fukami T, Nakajima M, Yokoi T (2014)
Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase
Drug Metabolism & Disposition: The Biological Fate of Chemicals 42: 1103

Tang SC, Sparidans RW, Cheung KL, Fukami T, Durmus S, Wagenaar E, Yokoi T, van Vlijmen BJ, Beijnen JH, Schinkel AH (2014)
P-Glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain and Blood Disposition of the mTOR Inhibitor Everolimus (Afinitor) in Mice
Clin Cancer Research 20: 3133

Higuchi R, Fukami T, Nakajima M, Yokoi T (2013)
Prilocaine- and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activation
Drug Metabolism & Disposition: The Biological Fate of Chemicals 41: 1220

Fukami T, Yokoi T (2012)
The emerging role of human esterases
Drug Metab Pharmacokinet 27: 466

Iwamura A, Fukami T, Higuchi R, Nakajima M, Yokoi T (2012)
Human alpha/beta hydrolase domain containing 10 (ABHD10) is responsible enzyme for deglucuronidation of mycophenolic acid acyl-glucuronide in liver
Journal of Biological Chemistry 287: 9240

Kobayashi Y, Fukami T, Nakajima A, Watanabe A, Nakajima M, Yokoi T (2012)
Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse
Drug Metabolism & Disposition: The Biological Fate of Chemicals 40: 671

Kobayashi Y, Fukami T, Shimizu M, Nakajima M, Yokoi T (2012)
Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liver
Drug Metabolism & Disposition: The Biological Fate of Chemicals 40: 1080

Shimizu M, Fukami T, Kobayashi Y, Takamiya M, Aoki Y, Nakajima M, Yokoi T (2012)
A novel polymorphic allele of human arylacetamide deacetylase leads to decreased enzyme activity
Drug Metabolism & Disposition: The Biological Fate of Chemicals 40: 1183

Kikuchi T, Cotton JA, Dalzell JJ, Hasegawa K, Kanzaki N, McVeigh P, Takanashi T, Tsai IJ, Assefa SA, Cock PJ, Otto TD, Hunt M, Reid AJ, Sanchez-Flores A, Tsuchihara K, Yokoi T, Larsson MC, Miwa J, Maule AG, Sahashi N, Jones JT, Berriman M (2011)
Genomic insights into the origin of parasitism in the emerging plant pathogen Bursaphelenchus xylophilus
PLoS Pathog 7: e1002219

Nakajima A, Fukami T, Kobayashi Y, Watanabe A, Nakajima M, Yokoi T (2011)
Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine
Biochemical Pharmacology 82: 1747

Fukami T, Takahashi S, Nakagawa N, Maruichi T, Nakajima M, Yokoi T (2010)
In vitro evaluation of inhibitory effects of antidiabetic and antihyperlipidemic drugs on human carboxylesterase activities
Drug Metabolism & Disposition: The Biological Fate of Chemicals 38: 2173

Holmes RS, Wright MW, Laulederkind SJ, Cox LA, Hosokawa M, Imai T, Ishibashi S, Lehner R, Miyazaki M, Perkins EJ, Potter PM, Redinbo MR, Robert J, Satoh T, Yamashita T, Yan B, Yokoi T, Zechner R, Maltais LJ (2010)
Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins
Mamm Genome 21: 427

Maruichi T, Fukami T, Nakajima M, Yokoi T (2010)
Transcriptional regulation of human carboxylesterase 1A1 by nuclear factor-erythroid 2 related factor 2 (Nrf2)
Biochemical Pharmacology 79: 288

Watanabe A, Fukami T, Takahashi S, Kobayashi Y, Nakagawa N, Nakajima M, Yokoi T (2010)
Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophen
Drug Metabolism & Disposition: The Biological Fate of Chemicals 38: 1532

Takahashi S, Katoh M, Saitoh T, Nakajima M, Yokoi T (2009)
Different inhibitory effects in rat and human carboxylesterases
Drug Metabolism & Disposition: The Biological Fate of Chemicals 37: 956

Watanabe A, Fukami T, Nakajima M, Takamiya M, Aoki Y, Yokoi T (2009)
Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis
Drug Metabolism & Disposition: The Biological Fate of Chemicals 37: 1513

Fukami T, Nakajima M, Maruichi T, Takahashi S, Takamiya M, Aoki Y, McLeod HL, Yokoi T (2008)
Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes
Pharmacogenet Genomics 18: 911

Minami K, Nakajima M, Fujiki Y, Katoh M, Gonzalez FJ, Yokoi T (2008)
Regulation of insulin-like growth factor binding protein-1 and lipoprotein lipase by the aryl hydrocarbon receptor
Journal of Toxicological Sciences 33: 405

Takahashi S, Katoh M, Saitoh T, Nakajima M, Yokoi T (2008)
Allosteric kinetics of human carboxylesterase 1: species differences and interindividual variability
J Pharm Sci 97: 5434

Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Ohara O, Isogai T, Sugano S (2004)
Complete sequencing and characterization of 21,243 full-length human cDNAs
Nat Genet 36: 40

Mushiroda T, Yokoi T, Itoh K, Nunoya K, Nakagawa T, Kubota M, Takahara E, Nagata O, Kato H, Kamataki T (2000)
The house musk shrew (Suncus murinus): a unique animal with extremely low level of expression of mRNAs for CYP3A and flavin-containing monooxygenase
Comparative Biochemistry & Physiology C Toxicol Pharmacol 126: 225